Brief: PZ Cormay Files For Registration Of Two Maglumi Immunological Reagents With Poland's Medicines Agency Regarding Covid-19
Feb 27 (Reuters) - PZ Cormay SA CRM.WA :
* FILES FOR REGISTRATIO OF TWO MAGLUMI IMMUNOLOGICAL
REAGENTS WITH
POLAND'S MEDICINES AGENCY REGARDING COVID-19
* TESTS ARE INTENDED FOR LAB IMMUNOLOGICAL DIAGNOSTICS AND
ENABLE
LABELING AMOUNTS OF ANTIBODIES AGAINST SARS-COV-2 CORONAVIRUS
* FILING FOR REGISTRATION WILL IMMEDIATELY ENABLE CO TO
START
DISTRIBUTION OF TESTS IN POLAND
Source text for Eikon: ID:nEM8R2VrDa
Further company coverage: CRM.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on PZ Cormay SA
See all newsBrief: PZ Cormay FY Net Result Turns To Loss Of 6.6 Mln Zlotys
Brief: PZ Cormay Decides To Start Review Of Strategic Options For Equisse 400i Project
Brief: PZ Cormay Estimates Q4 Sales Revenue At 21.8 Mln Zlotys, Down 11.2% Y/Y
Brief: PZ Cormay Q3 Net Result Turns To Profit Of 0.5 Mln Zlotys
Brief: PZ Cormay Appoints Marcin Sieczek As CEO